Cloning, expression and bioassay of canine CTLA4Ig

Veterinary Immunology and Immunopathology

Volumn 118, Issue 1-2, 2007, Pages 12-18

  Shin, Il Seob ^a   Choi, Eun Wha ^a   Chung, Jin Young ^a   Hwang, Cheol Yong ^a   Lee, Chang Woo ^a   Youn, Hwa Young ^a  

^a Seoul National University   (South Korea)

Author keywords

Chimeric fusion protein; Costimulatory pathway; CTLA 4; Dog; Mixed lymphocyte reaction; Protein expression

Indexed keywords

ABATACEPT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; NICKEL; NITRILOTRIACETIC ACID;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOASSAY; BIOLOGICAL ACTIVITY; CLONING; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DOG; ESCHERICHIA COLI; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION;

ANIMALS; BIOLOGICAL ASSAY; CELL PROLIFERATION; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; IMMUNOCONJUGATES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CONSTANT REGIONS; LEUKOCYTES, MONONUCLEAR; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 34250877470     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.03.013     Document Type: Article

References (18)

1. Bollag D.M., Rozycki M.D., and Edelsein S.J. Immunoblotting. In: Bollag D.M., Rozycki M.D., and Edelsein S.J. (Eds). Protein Methods. 2nd ed. (1996), Wiley-Liss, New York 195-227
2. Brunet J.F., Denizot F., Luciani M.F., Roux-Dosseto M., Suzan M., Mattei M.G., and Golstein P. A new member of the immunoglobulin superfamily-CTLA-4. Nature 328 6127 (1987) 267-270
3. Choi E.W., Shin I.S., Youn H.Y., Kim D.Y., Lee H., Chae Y.J., and Lee C.W. Gene therapy using non-viral peptide vector in a canine systemic lupus erythematosus model. Vet. Immunol. Immunopathol. 103 (2005) 223-233
4. Cohen S.N., Chang A.C., and Hsu L. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. U.S.A. 69 8 (1972) 2110-2114
5. Finck B.K., Linsley P.S., and Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 265 5176 (1994) 1225-1227
6. Freeman G.J., Lombard D.B., Gimmi C.D., Brod S.A., Lee K., Laning J.C., Hafler D.A., Dorf M.E., Gray G.S., Reiser H., et al. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 149 12 (1992) 3795-3801
7. Harper K., Balzano C., Rouvier E., Mattei M.G., Luciani M.F., and Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147 3 (1991) 1037-1044
8. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
9. Lenschow D.J., Zeng Y., Thistlethwaite J.R., Montag A., Brady W., Gibson M.G., Linsley P.S., and Bluestone J.A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257 5071 (1992) 789-792
10. Lindsten T., Lee K.P., Harris E.S., Petryniak B., Craighead N., Reynolds P.J., Lombard D.B., Freeman G.J., Nadler L.M., Gray G.S., et al. Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151 7 (1993) 3489-3499
11. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., and Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174 3 (1991) 561-569
12. Sayegh M.H. Finally, CTLA4Ig graduates to the clinic. J. Clin. Invest. 103 9 (1999) 1223-1225
13. Seligmann M., Mihaesco E., Preud'homme J.L., Danon F., and Brouet J.C. Heavy chain diseases: current findings and concepts. Immunol. Rev. 48 (1979) 145-167
14. Storb R., Yu C., Zaucha J.M., Deeg H.J., Georges G., Kiem H.P., Nash R.A., McSweeney P.A., and Wagner J.L. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94 7 (1999) 2523-2529
15. Traunecker A., Oliveri F., and Karjalainen K. Myeloma based expression system for production of large mammalian proteins. Trends Biotechnol. 9 4 (1991) 109-113
16. Turka L.A., Linsley P.S., Lin H., Brady W., Leiden J.M., Wei R.Q., Gibson M.L., Zheng X.G., Myrdal S., Gordon D., et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. U.S.A. 89 22 (1992) 11102-11105
17. Vallejo L.F., and Rinas U. Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb. Cell Fact. 3 1 (2004) 11-22
18. 3H-thymidine incorporation assay. Vet. Immunol. Immunopathol. 70 3-4 (1999) 151-159